|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0025266,
umls-concept:C0032659,
umls-concept:C0138741,
umls-concept:C0205210,
umls-concept:C0229671,
umls-concept:C0430420,
umls-concept:C0439275,
umls-concept:C0439810,
umls-concept:C0618743,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C1704243,
umls-concept:C1880497,
umls-concept:C1996904
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-5-30
|
|
pubmed:abstractText |
To investigate the clinical value of human glandular kallikrein 2 (hK2) compared with free (f) and total (t) prostate-specific antigen (PSA) in the early detection of prostate cancer (PCa).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0090-4295
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
694-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
|
|
pubmed:affiliation |
Department of Clinical Chemistry, Lund University, University Hospital Malmö, Malmö, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
